Skip to main content

Nasdaq IPOs

Fintech SPAC North Mountain Merger prices $115 million IPO at $10

6 years ago
North Mountain Merger, the second blank check company led by former CardConnect executives targeting the fintech industry, raised $115 million by offering 11.5 million units at $10 on Friday. North Mountain Merger began trading on the Nasdaq under the symbol NMMCU; units ended th
Renaissance Capital

Ocular disease biotech Graybug Vision sets terms for $75 million IPO

6 years ago
Graybug Vision, a Phase 2 biotech developing transformative medicines for ocular diseases, announced terms for its IPO on Monday. The Redwood City, CA-based company plans to raise $75 million by offering 4.7 million shares at a price range of $15 to $17. At the midpoint of the pr
Renaissance Capital

Rare disease biotech Spruce Biosciences files for an $86 million IPO

6 years ago
Spruce Biosciences, a Phase 2 biotech developing novel therapies for rare endocrine disorders, filed on Friday with the SEC to raise up to $86 million in an initial public offering. The company's lead candidate, tildacerfont, is being developed for classic congenital adrenal hype
Renaissance Capital
Checked
5 minutes 43 seconds ago
This feed is responsible for generating the rss feed related to the topic IPOs
Subscribe to Nasdaq IPOs feed